Hwaseong-si, South Korea

A Ram Lee

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: A Ram Lee. Retrieved from https://idiyas.com/inventor/a-ram-lee-jh00po4n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: A Ram Lee: Innovator in Immune-Stimulating Therapies

Introduction

A Ram Lee is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology through his innovative research and development efforts. His work focuses on creating novel therapeutic solutions that enhance immune responses.

Latest Patents

A Ram Lee holds a patent for a "Novel Conjugate of Immune-Stimulating IL-2 Analog and Preparation Method Thereof." This patent represents a breakthrough in the development of immune-stimulating therapies, which could have profound implications for treating various diseases.

Career Highlights

A Ram Lee is currently employed at Hanmi Pharmaceutical Co., Ltd., where he continues to advance his research in immunology. His expertise and dedication to innovation have positioned him as a key figure in the pharmaceutical industry.

Collaborations

A Ram Lee has collaborated with esteemed colleagues, including Yong Ho Heo and Euh Lim Oh. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

A Ram Lee's contributions to immunology through his patent and work at Hanmi Pharmaceutical Co., Ltd. highlight his role as an influential inventor in the field. His innovative approaches continue to pave the way for advancements in immune therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…